Eran Hodis

Active 2007–2022

16
Papers
22,060
Citations
16
h-index
16
i10-index

Citations

Citations per year for Eran Hodis1980: 1 citations1990: 1 citations1991: 1 citations2000: 1 citations2003: 1 citations2004: 2 citations2007: 1 citations2008: 5 citations2009: 8 citations2010: 9 citations2011: 10 citations2012: 36 citations2013: 299 citations2014: 518 citations2015: 628 citations2016: 641 citations2017: 659 citations2018: 541 citations2019: 1,169 citations2020: 1,267 citations2021: 1,013 citations2022: 764 citations2023: 475 citations2024: 670 citations2025: 333 citations2026: 18 citations1981–1989: no citations, so these years are not shown1992–1999: no citations, so these years are not shown2001–2002: no citations, so these years are not shown2005–2006: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,165 citing papers, 29.8% of this breakdownChina: 1,660 citing papers, 11.9% of this breakdownUnited Kingdom: 857 citing papers, 6.1% of this breakdownGermany: 740 citing papers, 5.3% of this breakdownItaly: 540 citing papers, 3.9% of this breakdownJapan: 465 citing papers, 3.3% of this breakdownFrance: 457 citing papers, 3.3% of this breakdownCanada: 448 citing papers, 3.2% of this breakdownSpain: 430 citing papers, 3.1% of this breakdownAustralia: 387 citing papers, 2.8% of this breakdownNetherlands: 319 citing papers, 2.3% of this breakdownSwitzerland: 300 citing papers, 2.1% of this breakdown
0%29.8%Other 22.9%

Fields

  • Biochemistry, Genetics and Molecular Biology51.9%
  • Medicine41.8%
  • Immunology and Microbiology3.1%
  • Computer Science1.3%
  • Engineering0.3%
  • Agricultural and Biological Sciences0.3%
  • Other1.3%

Topics

  • Cancer Genomics and Diagnostics8.2%
  • Lung Cancer Treatments and Mutations4.8%
  • Cancer Immunotherapy and Biomarkers4%
  • Melanoma and MAPK Pathways3.6%
  • RNA modifications and cancer2.9%
  • Epigenetics and DNA Methylation2.4%
  • Other74.1%

Coauthors

All papers

Open in search
  1. Comprehensive molecular profiling of lung adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rameen Beroukhim, Juok Cho, Daniel DiCara, David Heiman, Pei Lin, William Mallard, Douglas Voet, Hailei Zhang, Lihua Zou, Michael S. Noble, Nils Gehlenborg, Helga Thorvaldsdottir, Marc-Danie Nazaire, Jim Robinson, William Lee, Marc Ladanyi, Nikolaus Schultz, Ronglai Shen, William D. Travis, B. Arman Aksoy, Giovanni Ciriello, Gideon Dresdner, Jianjiong Gao, Benjamin Gross, Venkatraman E. Seshan, Boris Reva, Rileen Sinha, S. Onur Sumer, Nils Weinhold, Chris Sander, Natasha Rekhtman, Maureen Zakowski, Valerie W. Rusch, David G. Beer, Leslie Cope, Ludmila Danilova, James G. Herman, Stephen B. Baylin, Peter Illei, Edward Gabrielson, James Shin, Beverly Lee, Kristen Rodgers, Dante Trusty, Malcolm V. Brock, Chad J. Creighton, David Wheeler, Li Ding, Ramaswamy Govindan, Cyriac Kandoth, Robert Fulton, Lucinda L. Fulton, Michael D. McLellan, Richard K. Wilson, Kai Ye, Catrina C. Fronick, Christopher A. Maher, Christopher A. Miller, Michael C. Wendl, Christopher Cabanski, Elaine Mardis, Mark A. Watson, Sandra McDonald, Bryan Meyers, Raju Kucherlapati, Angela Hadjipanayis, Eran Hodis, Semin Lee, Angeliki Pantazi, Xiaojia Ren and 210 more - Nature 2014 cited by 5,918

  2. Mutational heterogeneity in cancer and the search for new cancer-associated genes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pei Lin, Lee Lichtenstein, David I. Heiman, Timothy R. Fennell, Marcin Imieliński, Bryan Hernandez, Eran Hodis, Sylvan C. Baca, Austin Dulak, Jens G. Lohr, Dan-Avi Landau, Catherine J. Wu, Jorge Meléndez-Zajgla, Alfredo Hidalgo‐Miranda, Amnon Koren, Steven A. McCarroll, Jaume Mora, Ryan S. Lee, Brian D. Crompton, Robert C. Onofrio, Melissa Parkin, Wendy Winckler, Kristin Ardlie, Stacey Gabriel, Charles W.M. Roberts, Jaclyn A. Biegel, Kimberly Stegmaier, Adam J. Bass, Levi A. Garraway, Matthew Meyerson, Todd R. Golub, Dmitry A. Gordenin, Shamil Sunyaev, Eric S. Lander, Gad Getz - Nature 2013 cited by 5,755

  3. Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq

    Authors: , , , , , , - eLife 2019 cited by 613

  4. A Landscape of Driver Mutations in Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael A. Davies, Jeffrey E. Gershenwald, Stephan N. Wagner, Dave S.�B. Hoon, Dirk Schadendorf, Eric S. Lander, Stacey Gabriel, Gad Getz, Levi A. Garraway, Lynda Chin - Cell 2012 cited by 2,643

  5. Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kristin Thompson, Wendy Winckler, David J. Kwiatkowski, Bruce E. Johnson, Pasi A. Jänne, Vincent A. Miller, William Pao, William D. Travis, Harvey I. Pass, Stacey Gabriel, Eric S. Lander, Roman K. Thomas, Levi A. Garraway, Gad Getz, Matthew Meyerson - Cell 2012 cited by 1,840

  6. Highly Recurrent TERT Promoter Mutations in Human Melanoma

    Authors: , , , , , - Science 2013 cited by 1,852

  7. The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Levi A. Garraway, Dirk Schadendorf - Cancer Discovery 2013 cited by 940

  8. RNF43 is frequently mutated in colorectal and endometrial cancers

    Authors: , , , , , , , , , , , , , , , , , - Nature Genetics 2014 cited by 476

  9. MAP Kinase Pathway Alterations in BRAF -Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 cited by 473

  10. Melanoma genome sequencing reveals frequent PREX2 mutations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alex H. Ramos, Trevor J. Pugh, Nicolas Stransky, Melissa Parkin, Wendy Winckler, Scott Mahan, Kristin Ardlie, Jennifer Baldwin, Jennifer A. Wargo, Dirk Schadendorf, Matthew Meyerson, Stacey Gabriel, Todd R. Golub, Stephan N. Wagner, Eric S. Lander, Gad Getz, Lynda Chin, Levi A. Garraway - Nature 2012 cited by 775

  11. Stepwise-edited, human melanoma models reveal mutations’ effect on tumor and microenvironment

    Authors: , , , , , , , , , , , , , , , , , , , - Science 2022 cited by 70

  12. The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2016 cited by 205

  13. Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2014 cited by 281

  14. Overlapping codes within protein-coding sequences

    Authors: , , - Genome Research 2010 cited by 81

  15. Proteopedia- a scientific 'wiki' bridging the rift between three-dimensional structure and function of biomacromolecules

    Authors: , , , , , - Genome biology 2008 cited by 104

  16. eMovie: a storyboard-based tool for making molecular movies

    Authors: , , , - Trends in Biochemical Sciences 2007 cited by 34

All 16 papers shown.